Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Asthma”

182 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 182 results

Large-scale testing (Phase 3)Study completedNCT02181335
What this trial is testing

Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy

Who this might be right for
Asthma
Boehringer Ingelheim 684
Testing effectiveness (Phase 2)Looking for participantsNCT07323654
What this trial is testing

KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Kymera Therapeutics, Inc. 264
Not applicableNot Yet RecruitingNCT06596512
What this trial is testing

Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

Who this might be right for
Moderate-to-Severe Asthma
Brigham and Women's Hospital 4,100
Large-scale testing (Phase 3)Study completedNCT00599027
What this trial is testing

An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

Who this might be right for
Allergic RhinitisAsthma
Organon and Co 51
Testing effectiveness (Phase 2)Study completedNCT00818454
What this trial is testing

4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 226
Large-scale testing (Phase 3)Study completedNCT01099722
What this trial is testing

Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma

Who this might be right for
Asthma
Mundipharma Research Limited 261
Testing effectiveness (Phase 2)Ended earlyNCT04946318
What this trial is testing

Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 136
Not applicableNot Yet RecruitingNCT07421115
What this trial is testing

Multicomponent Breathlessness and Physical Activity Intervention in People With Asthma Using a Digital Platform

Who this might be right for
Asthma (Diagnosis)Breathlessness
University of Newcastle, Australia 300
Large-scale testing (Phase 3)Study completedNCT04607629
What this trial is testing

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

Who this might be right for
Bronchial Asthma
AO GENERIUM 192
Post-approval studies (Phase 4)Study completedNCT01476059
What this trial is testing

Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT

Who this might be right for
Asthma
GlaxoSmithKline 472
Testing effectiveness (Phase 2)Study completedNCT00141791
What this trial is testing

Study Evaluating Etanercept in Moderate to Severe Asthma

Who this might be right for
Asthma
Wyeth is now a wholly owned subsidiary of Pfizer 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07372287
What this trial is testing

A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma

Who this might be right for
Moderate to Severe Asthma
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 230
Large-scale testing (Phase 3)Study completedNCT00163319
What this trial is testing

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)

Who this might be right for
Asthma
AstraZeneca 500
Large-scale testing (Phase 3)Study completedNCT00413387
What this trial is testing

Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)

Who this might be right for
Bronchial Asthma
Chiesi Farmaceutici S.p.A. 219
Large-scale testing (Phase 3)Active Not RecruitingNCT06920771
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Who this might be right for
House Dust Mite AllergyHouse Dust Mite Rhinitis
HAL Allergy 552
Testing effectiveness (Phase 2)WithdrawnNCT00967590
What this trial is testing

RO5036505 in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Hoffmann-La Roche
Post-approval studies (Phase 4)Study completedNCT01515995
What this trial is testing

Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation

Who this might be right for
Asthma
University of Texas Southwestern Medical Center 50
Not applicableUnknownNCT02489383
What this trial is testing

Comparison Between Continuous Versus Interval Exercise Training in Asthmatic Patients

Who this might be right for
Asthma
University of Sao Paulo General Hospital 60
Post-approval studies (Phase 4)Study completedNCT00480649
What this trial is testing

Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

Who this might be right for
Asthma
GlaxoSmithKline 424
Large-scale testing (Phase 3)Study completedNCT00482508
What this trial is testing

Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients

Who this might be right for
Asthma
Novartis 95
Load More Results